Exagen (XGN) Competitors $7.00 +0.22 (+3.24%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$7.02 +0.03 (+0.36%) As of 07/16/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XGN vs. CSTL, LFMD, CELC, OMDA, FTRE, AUNA, TALK, SBC, EHAB, and AIRSShould you be buying Exagen stock or one of its competitors? The main competitors of Exagen include Castle Biosciences (CSTL), LifeMD (LFMD), Celcuity (CELC), Omada Health (OMDA), Fortrea (FTRE), Auna (AUNA), Talkspace (TALK), SBC Medical Group (SBC), Enhabit (EHAB), and AirSculpt Technologies (AIRS). These companies are all part of the "healthcare" industry. Exagen vs. Its Competitors Castle Biosciences LifeMD Celcuity Omada Health Fortrea Auna Talkspace SBC Medical Group Enhabit AirSculpt Technologies Exagen (NASDAQ:XGN) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Do analysts prefer XGN or CSTL? Exagen presently has a consensus price target of $7.50, suggesting a potential upside of 7.14%. Castle Biosciences has a consensus price target of $37.00, suggesting a potential upside of 98.07%. Given Castle Biosciences' higher probable upside, analysts plainly believe Castle Biosciences is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, XGN or CSTL? Exagen has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Which has higher valuation & earnings, XGN or CSTL? Castle Biosciences has higher revenue and earnings than Exagen. Castle Biosciences is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$56.72M2.63-$15.11M-$0.84-8.33Castle Biosciences$332.07M1.62$18.25M-$0.19-98.32 Do institutionals and insiders hold more shares of XGN or CSTL? 75.3% of Exagen shares are held by institutional investors. Comparatively, 92.6% of Castle Biosciences shares are held by institutional investors. 12.6% of Exagen shares are held by insiders. Comparatively, 6.5% of Castle Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer XGN or CSTL? In the previous week, Castle Biosciences had 3 more articles in the media than Exagen. MarketBeat recorded 5 mentions for Castle Biosciences and 2 mentions for Exagen. Castle Biosciences' average media sentiment score of 1.14 beat Exagen's score of 0.94 indicating that Castle Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exagen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Castle Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is XGN or CSTL more profitable? Castle Biosciences has a net margin of -1.46% compared to Exagen's net margin of -27.34%. Castle Biosciences' return on equity of 3.41% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-27.34% -133.69% -34.87% Castle Biosciences -1.46%3.41%2.95% SummaryCastle Biosciences beats Exagen on 11 of the 15 factors compared between the two stocks. Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XGN vs. The Competition Export to ExcelMetricExagenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$144.41M$10.27B$5.51B$9.31BDividend YieldN/A2.07%4.25%4.09%P/E Ratio-8.3316.9728.1219.69Price / Sales2.6329.19439.46100.25Price / CashN/A22.2335.5357.53Price / Book12.963.598.235.67Net Income-$15.11M$233.40M$3.23B$257.51M7 Day PerformanceN/A-3.84%-0.52%-0.16%1 Month Performance-9.44%3.36%6.71%9.89%1 Year Performance241.46%-18.22%27.10%15.08% Exagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XGNExagen3.1496 of 5 stars$7.00+3.2%$7.50+7.1%+224.1%$144.41M$56.72M-8.33220Positive NewsCSTLCastle Biosciences2.2211 of 5 stars$19.46-4.1%$37.00+90.1%-4.3%$586.11M$332.07M-102.42540News CoveragePositive NewsLFMDLifeMD1.6305 of 5 stars$12.20-2.4%$12.00-1.6%+62.2%$568.09M$212.45M-35.88230Analyst ForecastCELCCelcuity2.1112 of 5 stars$13.34-3.3%$28.40+112.9%-25.8%$522.18MN/A-4.4040OMDAOmada HealthN/A$18.67+0.2%$23.57+26.3%N/A$479.72MN/A0.00849Quiet Period ExpirationFTREFortrea3.7885 of 5 stars$4.45-14.8%$15.00+237.1%-82.4%$472.41M$2.70B-0.5115,500Trending NewsAUNAAuna3.2607 of 5 stars$6.25-1.3%$10.70+71.3%-24.8%$468.50M$1.17B10.7714,842News CoverageTALKTalkspace3.7691 of 5 stars$2.65-4.3%$4.50+69.8%+7.8%$463.46M$187.59M132.57500Positive NewsSBCSBC Medical GroupN/A$4.51+0.9%N/AN/A$463.14M$205.42M0.00N/AEHABEnhabit3.2678 of 5 stars$7.31-4.4%$8.75+19.7%-29.2%$387.38M$1.03B-2.6410,700AIRSAirSculpt Technologies1.035 of 5 stars$5.39-0.2%$3.75-30.4%+15.9%$317.41M$180.35M-17.97240Positive News Related Companies and Tools Related Companies CSTL Alternatives LFMD Alternatives CELC Alternatives OMDA Alternatives FTRE Alternatives AUNA Alternatives TALK Alternatives SBC Alternatives EHAB Alternatives AIRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XGN) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XGN Stock Alerts